Fennec Pharmaceuticals (FENC) Profit After Tax Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 10.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.72% |
| Sep 30, 2025 | 56.95% |
| Jun 30, 2025 | 14.58% |
| Mar 31, 2025 | 31.31% |
| Dec 31, 2024 | 22.45% |
| Sep 30, 2024 | -10.81% |
| Jun 30, 2024 | -12.34% |
| Mar 31, 2024 | 66.48% |
| Dec 31, 2023 | 6.99% |
| Sep 30, 2023 | 31.61% |
| Jun 30, 2023 | -4.08% |
| Mar 31, 2023 | -16.78% |
| Dec 31, 2022 | -23.35% |
| Sep 30, 2022 | -64.59% |
| Jun 30, 2022 | -2.45% |
| Mar 31, 2022 | -11.04% |
| Dec 31, 2021 | -12.56% |
| Sep 30, 2021 | -15.31% |
| Jun 30, 2021 | -14.83% |
| Mar 31, 2021 | -46.31% |
| Dec 31, 2020 | -13.33% |
| Sep 30, 2020 | -35.39% |
| Jun 30, 2020 | -44.57% |
| Mar 31, 2020 | -67.68% |
| Dec 31, 2019 | -46.37% |
| Sep 30, 2019 | -52.86% |
| Jun 30, 2019 | -86.59% |
| Mar 31, 2019 | -84.22% |
| Dec 31, 2018 | -76.79% |
| Sep 30, 2018 | -181.68% |
| Jun 30, 2018 | -146.37% |
| Mar 31, 2018 | -121.44% |
| Dec 31, 2017 | -53.97% |
| Sep 30, 2017 | -101.57% |
| Jun 30, 2017 | -28.68% |
| Mar 31, 2017 | 36.81% |
| Dec 31, 2016 | -44.69% |
| Sep 30, 2016 | 34.25% |
| Jun 30, 2016 | -28.25% |
| Mar 31, 2016 | 53.24% |
| Dec 31, 2015 | 56.39% |
| Sep 30, 2015 | 45.60% |
| Jun 30, 2015 | 34.01% |
| Mar 31, 2015 | -59.75% |
| Dec 31, 2014 | -26.59% |
| Sep 30, 2014 | 28.48% |
| Jun 30, 2014 | -29.17% |
| Mar 31, 2014 | -38.97% |
| Dec 31, 2013 | 29.44% |
| Sep 30, 2013 | -44.90% |
| Jun 30, 2013 | 65.97% |